Beyond Nano, Challenges and Opportunities In Drug Delivery
Beyond Nano, Challenges and Opportunities In Drug Delivery
批准号:
10237745
负责人:
Yoon Yeo
金额:
$0.97万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-01 至 2022-03-31
关键词:
Applied ResearchAreaBiocompatible MaterialsBiologyChemistryChinaClinical TrialsCoffeeCommunicable DiseasesConsciousCountryDataDetectionDevelopmentDiagnosisDisciplineDiseaseDrug Delivery SystemsEngineeringEnsureExhibitsFeesGenderHealthHumanImmunotherapyInformaticsIsraelLearningMachine LearningMalignant NeoplasmsMedicineMinorityMinority GroupsMissionModerate ActivityPaperParticipantPerformancePersonsPharmacologic SubstancePostdoctoral FellowPreventionResearchResearch PersonnelScientistSeriesSocietiesTechnologyTissue EngineeringTravelUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesWashingtonbasecareerclinical translationdesignfallsglobal healthgraduate studentinnovationinterestlocal drug deliverymaterials sciencemedical specialtiesmeetingsmembermultidisciplinarynanonanomedicinephysical sciencepostersprogramssocialsuccesssymposiumtissue regenerationvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The Beyond Nano, Challenges and Opportunities in Drug Delivery symposium is one of the Soft Materials and
Biomaterials symposium clusters of the 2021 MRS Spring Meeting & Exhibit, to be held on April 18-23, 2021,
Seattle, Washington. The theme of the Beyond Nano, Challenges and Opportunities in Drug Delivery symposium
is the reflection on nano-/cancer-centric drug delivery research that has driven the field in past two decades and
the exploration of new opportunities in drug delivery technologies with a specific focus on a materials science
perspective. The MRS meeting is a unique forum for scientists at all levels, from eminent experts to young
scientists, in multiple disciplines related to materials science, including chemistry, engineering, and other applied
sciences. The MRS Soft Materials and Biomaterials symposia historically attracted the audience in the field of
drug delivery and tissue engineering with topics related to cutting-edge biomedical products. The objective of
this symposium is to provide a forum for investigators at all levels in allied disciplines including material scientists,
chemists, engineers, and pharmaceutical scientists and help them to share the lessons learned to date, discuss
the challenges and innovation in materials science in overcoming current bottlenecks in drug delivery, and
cultivate new opportunities that can benefit from the advances in nanomedicine. The organizing committee
consists of four experts in drug delivery field across the globe: Prof. Yoon Yeo of Purdue University (USA) chairs
the symposium, and Profs. Patrick Stayton of University of Washington (USA), Youqing Shen of Zhejiang
University (China), and Yosi Shamay (Israel) serve as co-chairs to plan, organize, and moderate activities of the
symposium. The committee has identified six thrust areas of fundamental and current interest in drug delivery
field: (i) Machine learning for drug delivery design; (ii) Nanomedicine; (iii) Bioinspired materials for drug delivery;
(iv) Local drug delivery; (v) Drug delivery for global health; and (vi) Biomaterials and drug delivery for
immunotherapy; and confirmed the participation of twenty-three leaders and rising stars as invited speakers.
We plan to achieve three Specific Aims through the Beyond Nano, Challenges and Opportunities in Drug
Delivery symposium: Aim 1. Critically reflect on the advances and challenges in core fields of drug delivery; Aim
2. Discuss the latest developments in materials science on emerging fields of drug delivery; Aim 3. Provide a
stimulating and dynamic convention to engage and inspire early-career scientists. The NIH symposium support
is being sought to support registration fees and travel expenses for invited speakers and young investigators,
prioritizing (i) early-career invited speakers, and (ii) graduate students, post-doctoral trainees, and young
investigators, including members of underrepresented minority groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Polysaccharide-based endotoxin antagonist for the treatment of sepsis
-
批准号:8954737
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2015
-
负责人:Yoon Yeo
-
依托单位:
Environmentally-adaptive nanoparticles with focal irradiation for cancer therapy
-
批准号:9241253
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2014
-
负责人:Yoon Yeo
-
依托单位:
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
-
批准号:10247756
-
项目类别:
-
资助金额:$40.8万
-
财政年份:2014
-
负责人:Yoon Yeo
-
依托单位:
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
-
批准号:10468237
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2014
-
负责人:Yoon Yeo
-
依托单位:
Environmentally-adaptive nanoparticles with focal irradiation for cancer therapy
-
批准号:8719708
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2014
-
负责人:Yoon Yeo
-
依托单位:
Environmentally-adaptive nanoparticles with focal irradiation for cancer therapy
-
批准号:9043877
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2014
-
负责人:Yoon Yeo
-
依托单位:
Environmentally-adaptive nanoparticles with focal irradiation for cancer therapy
-
批准号:8820268
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2014
-
负责人:Yoon Yeo
-
依托单位:
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
-
批准号:10002205
-
项目类别:
-
资助金额:$40.8万
-
财政年份:2014
-
负责人:Yoon Yeo
-
依托单位:
Peritumorally transformable nanoparticles for intraperitoneal chemotherapy of ova
-
批准号:7777411
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2009
-
负责人:Yoon Yeo
-
依托单位:
Peritumorally transformable nanoparticles for intraperitoneal chemotherapy of ova
-
批准号:7659971
-
项目类别:
-
资助金额:$16.61万
-
财政年份:2009
-
负责人:Yoon Yeo
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: